buprenorphine (Q407721)

buprenorphine(English)

18 November 2016

chemical formula

C₂₉H₄₁NO₄

1 reference

buprenorphine(English)

18 November 2016

canonical SMILES

CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O

1 reference

buprenorphine(English)

18 November 2016

isomeric SMILES

C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O

1 reference

buprenorphine(English)

18 November 2016

defined daily dose

8milligram

sublingual administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N07BC01

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

buprenorphine(English)

1 reference

Chemiluminescence detection of opium poppy (Papaver somniferum) alkaloids

buprenorphine(English)

3 October 2016

1 reference

medical condition treated

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

osteoarthritis susceptibility 1

13 December 2016

1 reference

2 October 2018

migraine

1 reference

2 October 2018

fibromyalgia

1 reference

2 October 2018

arthritis

1 reference

2 October 2018

substance abuse

1 reference

2 October 2018

peripheral neuropathy

1 reference

Food and Drug Administration

2 October 2018

30 June 2010

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/40D3SCR4GZ

2 November 2018

reference URL

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020732s014s015lbl.pdf

significant drug interaction

saquinavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Ketoconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpheniramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

itraconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

itraconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atazanavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atazanavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosamprenavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lopinavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

darunavir

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimeprazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zopiclone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dexmedetomidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perampanel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-thiopental

1 reference

A reference set of clinically relevant adverse drug-drug interactions

midazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-baclofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zolpidem

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alprazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluphenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

loxapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

loxapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

loxapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

primidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

opioid receptor kappa 1

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

1 reference

17 August 2016

intravenous infusion and defusion

0 references

intramuscular injection

0 references

sublingual administration

0 references

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.(English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

0 references

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Buprenorphine

0 references

topic's main category

Category:Buprenorphine

0 references

Identifiers

NL CR AUT ID

ph392394

subject named as

buprenorfin

0 references

InChI

InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1

1 reference

buprenorphine(English)

18 November 2016

2 references

buprenorphine(English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

52485-79-7

2 references

buprenorphine(English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=52485-79-7

10 April 2021

1 reference

Buprenorphine(English)

18 November 2016

2 references

buprenorphine(English)

18 November 2016

Reaxys registry number

6182863

1 reference

buprenorphine(English)

3 October 2016

ChEBI ID

3216

mapping relation type

2 references

CHEMBL560511(English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1

1 reference

CHEMBL560511(English)

18 November 2016

2 references

inferred from InChIKey

1 reference

MassBank accession ID

MSBNK-Waters-WA000944

0 references

MSBNK-Waters-WA000945

0 references

MSBNK-Waters-WA000946

0 references

MSBNK-Waters-WA000947

0 references

DSSTox substance ID

DTXSID2022705

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

1 reference

buprenorphine(English)

ECHA Substance Infocard ID

18 November 2016

100.052.664

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.052.664

27 December 2018

Buprenorphine(English)

quotation

CAS no.: 52485-79-7(English)

1 reference

Buprenorphine(English)

17 November 2015

1 reference

Buprenorphine(English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

buprenorphine(English)

18 November 2016

Buprenorphine

0 references

0 references

0 references

0 references

0 references

0 references

1 reference

buprenorphine(English)

18 November 2016

DrugBank ID

DB00921

1 reference

Human Metabolome Database ID

HMDB0015057

2 references

based on heuristic

inferred from InChIKey

2 references

buprenorphine(English)

18 November 2016

MedlinePlus drug identifier

a616019

medical condition treated

buccal administration

chronic pain

0 references

a618015

subcutaneous injection

0 references

a605002

sublingual administration

buccal administration

medical condition treated

opioid dependence, susceptibility to, 1

0 references

a613042

0 references

1 reference

buprenorphine(English)

18 November 2016

0 references

1 reference

1 reference

buprenorphine(English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

buprenorphine(English)

3 October 2016

0 references

1 reference

28 October 2013

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

1 reference

Store medisinske leksikon ID

buprenorfin

mapping relation type

exact match

subject named as

buprenorfin

1 reference

Great Norwegian Encyclopedia

UK Parliament thesaurus ID

15 March 2020

449828

subject named as

Buprenorphine

0 references

UMLS CUI

C0006405

1 reference

buprenorphine(English)